Belden Inc.: Form 10-Q for the period ended Jul 3, 2022
Filed with the SEC on Aug 8, 2022 and accepted by EDGAR at Aug 8, 2022, 12:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-07-03. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-04-04 to 2022-07-03 | $666.6m | us-gaap:Revenues |
| Revenue | 6 months2022-01-01 to 2022-07-03 | $1.28bn | us-gaap:Revenues |
| Cost of revenue | 3 months2022-04-04 to 2022-07-03 | $444.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2022-01-01 to 2022-07-03 | $845.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-04-04 to 2022-07-03 | $222.3m | us-gaap:GrossProfit |
| Gross profit | 6 months2022-01-01 to 2022-07-03 | $431.2m | us-gaap:GrossProfit |
| Research and development | 3 months2022-04-04 to 2022-07-03 | $26.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-01-01 to 2022-07-03 | $49.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-04-04 to 2022-07-03 | $105.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-01-01 to 2022-07-03 | $208.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-04-04 to 2022-07-03 | $81.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-01-01 to 2022-07-03 | $155.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-04-04 to 2022-07-03 | $13.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-01-01 to 2022-07-03 | $22.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-04-04 to 2022-07-03 | $58.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-01-01 to 2022-07-03 | $94.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-04-04 to 2022-07-03 | $1.31 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-01-01 to 2022-07-03 | $2.09 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-04-04 to 2022-07-03 | $1.32 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-01-01 to 2022-07-03 | $2.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-04-04 to 2022-07-03 | 44,782,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-01-01 to 2022-07-03 | 45,179,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-01-01 to 2022-07-03 | −$8.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-01-01 to 2022-07-03 | $31.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2022-01-01 to 2022-07-03 | $4.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2022-07-03 | $527.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-07-03 | $1.41bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-07-03 | $3.03bn | us-gaap:Assets |
| Current liabilities | At period end2022-07-03 | $590.3m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2022-07-03 | $1.14bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2022-07-03 | $1.05bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000913142-22-000023. Last ingested by Listed: Oct 29, 2026, 14:50 ET. Listed shows no prices and gives no investment advice.